IRD

Opus Genetics, Inc. Common Stock

31 hedge funds and large institutions have $5.71M invested in Opus Genetics, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-4
Holders Change %
-11.43%
% of All Funds
0.9%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
8
Reduced
7
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Citigroup
26
Citigroup
New York
$6K -$4.8K -12 -44%
Canada Life
27
Canada Life
Manitoba, Canada
$5K
TRCT
28
Tower Research Capital (TRC)
New York
$3K -$750 -2 -20%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$1K -$1K -2 -50%
Ameriprise
30
Ameriprise
Minnesota
$1K
CP
31
Corbenic Partners
Pennsylvania
$1K
Morgan Stanley
32
Morgan Stanley
New York
-$1.08M -2,575 Closed
OC
33
Oppenheimer & Co
New York
-$23K -56 Closed
U
34
UBS
Switzerland
-$17K -40 Closed
Two Sigma Investments
35
Two Sigma Investments
New York
-$16K -39 Closed
FNYS
36
First New York Securities
New York
-$13.1K -31 Closed
CS
37
Credit Suisse
Switzerland
-$10K -24 Closed
Fisher Asset Management
38
Fisher Asset Management
Washington
-$9K -21 Closed